Top Markets
Coin of the day
Aceragen, Inc. Aceragen, Inc.

Aceragen, Inc.

ACGN
Rangering i aksjer #39036
Aceragen, Inc., a biopharmaceutical firm in its clinical development phase,... Aceragen, Inc., a biopharmaceutical firm in its clinical development phase, operates out of Exton, Pennsylvania, and was founded in 1989. The company, which transitioned from Idera Pharmaceuticals, Inc. and adopted its current name in January 2023, concentrates on the discovery, advancement, and bringing to market of therapeutic agents for uncommon lung and autoimmune conditions exclusively within the United States. Its product development pipeline includes ACG-701, currently undergoing Phase 2 clinical evaluation for both cystic fibrosis pulmonary exacerbations and melioidosis, as well as ACG-801, which is being developed to address Farber disease. Moreover, Aceragen maintains a partnership and option agreement with Scriptr Global, Inc. This collaboration aims to pinpoint, research, and cultivate gene therapy options intended for the management, palliation, diagnosis, or prevention of myotonic dystrophy type 1 and Friedreich's Ataxia.
Aksjekurs
$0.38
Sist synkronisert: 2023-09-01
Markedsverdi
$677.16K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Aceragen, Inc. (ACGN)

Kategori

Pris ACGN pris med markedsverdi på B
Aceragen, Inc. Aceragen, Inc.
ACGN
$0.38
Markedsverdi av Aceragen, Inc.(ACGN)
Markedsverdi: $677.16K
Per August 2026 har Aceragen, Inc. en markedsverdi på $677.16K. Dette gjør Aceragen, Inc. til det 39036th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Aceragen, Inc. fra 1996 til 2026
ACGN sammenlignet med topp 5 mest populære stocks
Pris på ACGN Eiendel B Markedsverdi for B Resultater
Aceragen, Inc. Aceragen, Inc.
$3,073,838 $677.16K
$5.478T +808,904,612.33%
Aceragen, Inc. Aceragen, Inc.
$2,518,651 $677.16K
$4.488T +662,802,717.32%
Aceragen, Inc. Aceragen, Inc.
$2,336,400 $677.16K
$4.163T +614,841,895.13%
Aceragen, Inc. Aceragen, Inc.
$2,078,821 $677.16K
$3.704T +547,057,963.68%
Aceragen, Inc. Aceragen, Inc.
$1,594,550 $677.16K
$2.841T +419,618,301.12%